These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12130457

  • 21. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
    Prechtel HW, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM, Behrendt FF.
    Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
    [Abstract] [Full Text] [Related]

  • 22. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [Abstract] [Full Text] [Related]

  • 23. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
    Antoch G, Freudenberg LS, Egelhof T, Stattaus J, Jentzen W, Debatin JF, Bockisch A.
    J Nucl Med; 2002 Oct; 43(10):1339-42. PubMed ID: 12368372
    [Abstract] [Full Text] [Related]

  • 24. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.
    Nakamoto Y, Osman M, Cohade C, Marshall LT, Links JM, Kohlmyer S, Wahl RL.
    J Nucl Med; 2002 Sep; 43(9):1137-43. PubMed ID: 12215550
    [Abstract] [Full Text] [Related]

  • 25. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN, Francis IR.
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [Abstract] [Full Text] [Related]

  • 26. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
    Rebière M, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM, Behrendt FF.
    Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
    [Abstract] [Full Text] [Related]

  • 27. Incidental colonic focal lesions detected by FDG PET/CT.
    Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, Corone C, Tainturier C, Pecking AP.
    AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
    [Abstract] [Full Text] [Related]

  • 28. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Positron emission tomography/computed tomography.
    Townsend DW.
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 May; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 35. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL.
    Cancer Res; 2003 Oct 01; 63(19):6252-7. PubMed ID: 14559811
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.